Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-735P represents a **pseudogene** of the **U6 small nuclear RNA** (snRNA) family[1][2]. The canonical U6 snRNA is crucial for pre-mRNA splicing as part of the spliceosome complex[3][5]. Pseudogenes like RNU6-735P are non-coding regions, derived from functional genes but lacking the ability to encode functional products. While once thought to be nonfunctional, some pseudogenes may be transcribed and participate in gene regulation through various mechanisms (for example, acting as miRNA decoys or sources of non-coding RNAs involved in RNA interference pathways)[6][4]. However, there is no evidence that RNU6-735P itself encodes a functional RNA molecule or is a direct therapeutic target. This pseudogene is best classified as a genomic element of uncertain or regulatory potential but is not considered a canonical receptor, enzyme, transporter, or established therapeutic target[1][2][5]. The U6 pseudogene may be present in multiple copies throughout the genome, reflecting a common phenomenon among small nuclear RNA genes[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 735, pseudogene (RNU6-735P).